MB-097

N/A

Report date: 2024/08/07 20:00:43

Base Information

Drug NameMB-097
Drug Alias NameMB-097
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsCD8-positive T-Lymphocytes stimulantsMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyUnited KingdomFrance +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMicrobiotica Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMicrobiotica Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A